Box Layout

HTML Layout
Backgroud Images
Backgroud Pattern
  • E-mail : info_medicalmarketing@jindunmedical.com
  • Phone : +86 21 64057580
  • Address : Shanghai China

Gabapentin, epilepsy and headache together

  • 2022-10-09
  • JINDUN MEDICAL

Gabapentin is a new type of anti-epileptic drug that was launched in the UK in 1993 and has since been qualified for marketing in over 50 countries, and was also approved for produ

LEES VERDER

Detection of 3-aminopiperidine in alogliptin benzoate by ion chromatography

  • 2022-10-09
  • JINDUN MEDICAL

Detection of 3-aminopiperidine in alogliptin benzoate by ion chromatography

LEES VERDER

Affordable diabetes drug "Linagliptin" has a preventive effect on cardiovascular disease!

  • 2022-10-08
  • JINDUN MEDICAL

Obesity and type 2 diabetes are associated with the development of vascular sclerosis and cardiovascular disease.

LEES VERDER

Scientists find unexpected "benefits" of diabetes drug Linagliptin

  • 2022-10-08
  • JINDUN MEDICAL

Recipes rich in fat and refined sugar have increased the number of obese and type 2 diabetics worldwide, and menopausal women with obesity and diabetes have a greater risk of heart

LEES VERDER

Erythromycin status analysis, future market price can be expected!

  • 2022-10-08
  • JINDUN MEDICAL

Erythromycin is one of the bulk products exported from China's pharmaceutical raw materials, with a long-term export volume of thousands of tons and hundreds of millions of dol

LEES VERDER

How do I take azithromycin correctly?

  • 2022-10-08
  • JINDUN MEDICAL

The mechanism of action of Azithromycin is similar to Erythromycin.

LEES VERDER

Recommend-Acetoxy Empagliflozin-Manufacturer

  • 2022-10-08
  • JINDUN MEDICAL

Acetoxy Empagliflozin is an intermediate for the synthesis of Empagliflozin. Empagliflozin, a sodium glucose cotransporter (SGLT2) inhibitor developed by Boehringer Ingelheim and L

LEES VERDER

Recommend-Empagliflozin-Manufacturer

  • 2022-10-08
  • JINDUN MEDICAL

Empagliflozin is hypoglycemic drugs. Sodium glucose cotransporter 2 (SGLT-2) is a major transporter that reabsorbes glucose from glomerular filtrate into blood circulation.

LEES VERDER

Recommend-Sitagliptin base-Manufacturer

  • 2022-10-08
  • JINDUN MEDICAL

Sitagliptin is a new anti type II diabetes drug approved by FDA and the first dipeptidyl peptidase IV inhibitor used to treat type II diabetes.

LEES VERDER

US p-nitrobenzoic acid import customs clearance operation process

  • 2022-10-08
  • JINDUN MEDICAL

P-nitrobenzoic acid belongs to chemical goods, simple introduction of customs clearance process

LEES VERDER